Athira Pharma, Inc.ATHANASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-95.81M
↓ 73% below average
Average (6y)
$-55.52M
Historical baseline
Range
High:$-79000.00
Low:$-125.97M
CAGR
+226.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-95.81M | +23.9% |
| 2023 | $-125.97M | -43.1% |
| 2022 | $-88.01M | -61.9% |
| 2021 | $-54.37M | -177.6% |
| 2020 | $-19.59M | -306.9% |
| 2019 | $-4.81M | -5992.4% |
| 2018 | $-79000.00 | - |